Voice your opinion on congressional bill HR1613-118 and let lawmakers know your stance with UnPac!

Drug Price Transparency in Medicaid Act of 2023

This bill requires pass-through pricing models, and prohibits spread-pricing, for payment arrangements with pharmacy benefit managers under Medicaid. The bill also extends funding for retail pharmacy surveys and requires additional information with respect to price concessions and survey participation to be made publicly available.

S1038-118, HR3561-118,

House committee actions Actions

Committee
Mar. 24 2023	Referred to the Subcommittee on Health.

House floor actions Actions

IntroReferral
Mar. 17 2023	Referred to the House Committee on Energy and Commerce.

Library of Congress Actions

IntroReferral
Mar. 17 2023	Introduced in House Introduced in House

House bill HR1613-118

Drug Price Transparency in Medicaid Act of 2023

House bill HR1613-118

Drug Price Transparency in Medicaid Act of 2023

Promote the cause!

Or use this QR code